Home / Intelligence

Type
  • All
  • Analyst Reports
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Customer Engagement
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • Medical Affairs
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Sustainability
  • Talent Acquisition and Retention
  • United States
  • Value Communication
Search

Webinars

The GenAI Advantage: Empowering Pharma Customer-Facing Teams

June 11, 2025 | 1:00 - 1:45 PM ET

Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences companies. Discover practical applications of GenAI to enhance call planning and customer engagement and help field teams translate data and analytics into action.

Sign Up Now

Webinars

Navigating the Early Asset Evaluation Journey with Confidence

Available On Demand

There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common…

Watch Now

Blog

Learnings to Kick-Start 2025: Health Equity

Published January 28, 2025

Health equity continues to be a hot topic in the life sciences industry. ISPOR EU sessions addressed several key questions surrounding the impact of health equity on HTA decision-making, the methodologies that should be employed, and the opportunities and challenges of incorporating health equity into health technology assessment (HTA). Ahead of ISPOR EU, Trinity’s HTA Vision team analyzed the impact of health equity on HTA agency behavior across six recent pharmaceutical launches and seven countries: Australia, Canada, England, France, Germany,…

Read Now

Blog

Maximum Fair Price Round 2: Passing the Baton

Published January 24, 2025

On January 20, 2025, CMS announced the set of fifteen drugs targeted for the second round of Maximum Fair Price (MFP) “negotiations” under IRA. With the outcomes of the first price “negotiations” announced only last August, the IRA MFP process is still in its early development and there remains uncertainty over how it will evolve – particularly in terms of the extent to which CMS will aim for true drug cost reductions vs. generating political capital via nominal “savings” on…

Read Now

Blog

Learnings to Kick-Start 2025: Climate Resilience and Environmental Sustainability

Published January 21, 2025

Trinity recently presented a poster on climate resilience and environmental sustainability at ISPOR EU, titled “Attitudes and Perceptions on Environmental Sustainability Efforts in the Life Sciences Industry: A Cross-Sectional Survey from HEOR and Industry Professionals.” The poster discussed results from a recent survey conducted by our CREST (Climate Resilience and Environmental Sustainability at Trinity) team, which identified perceptions regarding life sciences industry efforts to tackle sustainability, particularly within HEOR, evidence generation and value communication strategy. We also published our new…

Read Now

Blog

Learnings to Kick-Start 2025: Joint Clinical Assessments and Health Technology Assessments

Published January 17, 2025

One trend Trinity Life Sciences has observed and that was reinforced by stakeholders at ISPOR EU is the importance of evidence in healthcare decision-making. This trend was highlighted particularly in the context of joint clinical assessments (JCA) and health technology assessments (HTA). Trinity presented 11 posters at ISPOR EU, 6 of which focused on HTA and/or JCA. JCA is an EU initiative intended to improve patient access to health technologies in Europe through a harmonized clinical HTA process. Beginning in January…

Read Now

Blog

Solving the Cell & Gene Therapy Access Puzzle in the U.S.

Published January 10, 2025

Cell and gene therapies (CGTs) have ushered in a new era of medicine, offering patients transformative, even potentially curative solutions, with a single treatment. Despite the clinical promise, barriers to patient access remain given administration complexity, gaps in patient outcome evidence and high costs. As cell and gene therapies become available in new indications beyond oncology and rare pediatric diseases, developers of innovative therapies need to develop strategies targeting patients, providers and payers to overcome these challenges and promote access…

Read Now

Webinars

A Massive Change Ahead in CRM: Predictions and Implications for Pharma

Available On Demand

Are you ready for the transition and change being forced on the pharmaceutical industry given the unprecedented Customer Relationship Management (CRM) changes announced by Veeva, Salesforce and IQVIA?   The status quo is not an option. Life science companies are being forced to evaluate the implications on their customer strategy and operations as the CRM is one piece of an increasingly integrated ecosystem. The CRM decision will influence commercial and medical data strategy and management, commercial interface architectures, marketing automation…

Watch Now

Blog

Transforming Data Operations: Adding Value with an Automated, Scalable Data Foundation 

Published January 6, 2025

In today’s fast-paced business environment, the ability to harness data effectively can be a game-changer. Companies that can quickly integrate and analyze data from various sources are better positioned to make informed decisions, optimize operations and stay ahead of the competition.   The complexity of managing diverse data sources, ensuring data quality and maintaining consistent performance metrics can be daunting. These challenges are often exacerbated during periods of rapid growth, such as when a company is acquiring new businesses and integrating…

Read Now

Blog

5 Key Trends in Global Market Access

Published December 12, 2024

Key impacts on the market access and payer environment are beginning to unfold from policies enacted in 2023 and new policies enacted in 2024. To gather insights into the latest trends, Trinity Life Sciences conducted interviews with key stakeholders across various pricing and market access landscapes. Trinity is closely monitoring the evolving global advanced therapeutics market environment, including the trends below, to determine implications for payers and manufacturers and help them prepare for the year ahead. Key Trends Continued Emphasis…

Read Now

Blog

Is Medical Omnichannel Poised for Growth?

Published December 10, 2024

79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel.    What is Medical Omnichannel?  Medical omnichannel is an orchestrated approach to scientific engagement, leveraging analytics and insights to optimize educational content and channels in a customer-centric…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.